Tenon Medical(TNONW)

Focus: Tenon Medical is a public medical device company focused on surgical solutions for chronic lower back pain, specifically sacroiliac joint disruption. The company is early-stage in commercialization with $3M in FY 2025 revenue.

Musculoskeletal

Profile data last refreshed 14h ago · AI intelligence enriched 3w ago

Funding Stage

PUBLIC

Open Jobs

About Tenon Medical

AI assessmentNot Hiring

No open roles listed right now. Follow Tenon Medical to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

4/9 — Basic

Company HealthSolid

Pipeline

Early-stage

2 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Revenue

$3M

FY2025

Pipeline & Clinical Trials

CATAMARAN SI Joint Fusion System

Sacroiliac Joint Disruption

N/A

Clinical Trials (1)

NCT05633888Post-Market Feasibility Study of the Tenon Medical CATAMARAN™ SI Joint Fusion System

N/A

Help build intelligence for Tenon Medical

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

79% R&D intensity indicates heavy investment in product development and innovation for your skill growth.
Public company status provides liquidity and potential equity upside as the CATAMARAN SI Joint Fusion System scales.
Focused musculoskeletal device niche offers deep domain expertise in an underserved surgical market.

Watch Out For

Company is pre-revenue with $13.7M net loss in FY 2025 and only $7M cash on hand—runway concerns and restructuring risk are real.
Zero active job openings currently listed; hiring appears frozen despite analyst bullishness, suggesting internal headcount constraints.

Generated by Claude from Tenon Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pelvic CT Scan

Sacroiliac Joint Disruption

N/A

Clinical Trials (1)

NCT05628142Tenon Medical CATAMARAN™ SI Joint Fusion System CT Scan Study

N/A

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Founded: 2000

Portfolio: 2 clinical trials

Publications: 5 in PubMed

SEC Filings: 2 available

Financials (FY2025)

Revenue

$3M12%

R&D Spend

$3M(79%)18%

Net Income

-$14M

Research Publications(5)

Recent peer-reviewed publications with author affiliations at this company

Twelve-month clinical and radiographic outcomes following inferior-posterior sacroiliac joint fusion using the Catamaran SI Joint Fusion System: a prospective, multi-center evaluation.

Expert review of medical devices

2025

PMID:40773478

Catamaran SI Joint Fusion System((R)) MAINSAIL(TM) Study: a prospective, single-arm, multi-center, post-market study of six-month clinical outcomes and twelve-month radiographic findings.

Expert review of medical devices

2024

PMID:39161110

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo